Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.56 |
| ▸ | GSK3A | P49840 | 4/20 | 0.56 |
| ▸ | GSK3B | P49841 | 4/20 | 0.56 |
| ▸ | FAAH | O00519 | 4/20 | 0.46 |
| ▸ | ELANE | P08246 | 3/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | PLG | P00747 | 1/20 | 0.42 |
| ▸ | CTSG | P08311 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24478757 | 0.78 | MGLL (0.61) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL24478879 | 0.75 | MGLL (0.49) | MGLLGSK3AGSK3BFAAHMEN1 | |
| SCHEMBL28256798 | 0.75 | MGLL (0.69) | MGLLGSK3AGSK3BFAAHMEN1 | |
| SCHEMBL8189917 | 0.74 | MGLL (0.67) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL207740 | 0.74 | MGLL (1.00) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL25435490 | 0.74 | MGLL (1.00) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL598742 | 0.70 | MGLL (0.64) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL1908629 | 0.70 | MGLL (0.64) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL28923787 | 0.69 | MGLL (0.57) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL28874121 | 0.68 | MGLL (0.78) | MGLLGSK3AGSK3BFAAHELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479799-B2 | Bioconjugation reagent and methods | UNIVERSITEIT GENT (BE) | 2025-11-25 | — | — | US | disclosed |
| US-20220169604-A1 | BIOCONJUGATION REAGENT AND METHODS | UNIVERSITEIT GENT (BE) | 2022-06-02 | — | — | US | disclosed |
| US-9593108-B2 | Compounds and methods for antiviral treatment | PTC THERAPEUTICS, INC. (US) | 2017-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169604-A1 | BIOCONJUGATION REAGENT AND METHODS | PIGS, MACF1, PTMA | MGLL 1426/4885GSK3A 1727/4885GSK3B 1646/4885 |
| US-12479799-B2 | Bioconjugation reagent and methods | PIGS, MACF1, PTMA | MGLL 1426/4885GSK3A 1727/4885GSK3B 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.